Form 8-K - Current report:
SEC Accession No. 0001104659-24-063653
Filing Date
2024-05-21
Accepted
2024-05-21 07:04:45
Documents
15
Period of Report
2024-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414924d1_8k.htm   iXBRL 8-K 29752
2 EXHIBIT 99.1 tm2414924d1_ex99-1.htm EX-99.1 10224
6 GRAPHIC tm2414924d1_ex99-1img01.jpg GRAPHIC 2400
  Complete submission text file 0001104659-24-063653.txt   220492

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20240517.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20240517_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20240517_pre.xml EX-101.PRE 22355
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2414924d1_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 24966819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)